INTRODUCTION
In recent years, there has been increasing interest on the use of bioadhesive polymers. Per oral drug delivery has been the most widely utilized route of administration for the systemic delivery of drugs. The lack of efficacy of certain drugs due to decreased bioavailability, unpredictable and erratic absorption, GI intolerance or pre-systemic elimination has prompted the examination of other potential routes for administration. Moreover, the recent development of a large number of peptides as drugs has intensified investigation of mucosal delivery of drugs (Vinod et al., 2012) . Such routes exploring other absorptive mucosa include the oral, nasal, buccal, rectal, vaginal and ocular to a limited extend, pulmonary routes amongst the various route of drug delivery, oral route is perhaps the most preferred to the patient and the clinician alike. However, per oral administration of drugs has disadvantages such as hepatic first pass metabolism and enzymatic degradation within the GIT, that prohibit oral administration of certain classes of drugs especially peptides and proteins. Consequently, other absorptive mucosa is considered as potential sites for drug administration (Vyas and Khar, 2002) .
Simvastatin is HMG Co-A (3-hydroxy-3-methylglutaryl-CoA) reductase inhibitors widely used in the treatment of hyper cholesterolemia, as it reduces levels of low-density lipoproteins and triglycerides, and raises high-density lipoprotein levels. Simvastatin undergoes extensive first pass metabolism in liver due to which the oral bioavailability is less dose size i.e., in few mg. Hence, it is suitable candidate for mucoadhesive drug delivery (Goud et al., 2011) .
In this study, the main objective is to develop and evaluate mucoadhesive tablets of Simvastatin by employing various natural hydrophilic bioadhesive polymers such as xanthan gum, chitosin, guar gum and carbopol for prolonged gastrointestinal absorption. The prepared tablets were evaluated for different parameters such as hardness, friability, weight variation, swelling index, invitro residence time and ex-vivo adhesive time.
MATERIALS AND METHODS
Simvastatin was collected as a gift sample from Aurobindo Pharma Ltd., Hyderabad, polymers were purchased from Yarrow Chem Products, Mumbai and all remaining excipients were purchased from Scientific Lab, Erode.
IR studies of Simvastatin with natural polymers Infrared spectra analysis
Compatibility of the drug with the excipients was determined by subjecting the physical mixture of the drug and polymer of the main formulation to infrared spectral analysis. Any changes in chemical composition of the drug after the combining it with the polymers were investigated with IR spectral analysis (Harry, 2006) . Infrared spectrum of simvastatin was determined on Fourier transform infrared spectrophotometer using KBr pellet method. The base line correction was done using dried potassium bromide. Then the spectrum of the dried mixture of the drug and potassium bromide was done.
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average weight by 10% and none should deviate by more than twice that percentage. The average weight and standard deviation of the tablets were calculated.
Hardness test
There is a certain requirement of hardness in tablets so as to withstand the mechanical shocks during handling, manufacturing, packaging and shipping. For each formulation, the hardness of 6 tablets was determined using the Monsanto hardness tester. Monsanto hardness tester was used to measure hardness of the tablets. The whole experiment was performed in triplicate and the results are expressed in kg/cm 2 unit.
Friability test
Friability is the measure of tablet strength. This test subjects a number of tablets to the combined effect of shock abrasion by utilizing a plastic chamber which revolves at a speed of 25 rpm for 4 minutes, dropping the tablets to a distance of 6 inches in each revolution. A sample of pre-weighed tablets was placed in Roche friabilator which was then operated for 100 revolutions. The tablets were then dedusted and reweighed. Generally considered and acceptable limit is loss of less than 1% in weight. Percent friability (%F) was calculated.
In-vitro swelling study (water uptake study)
The tablets of each formulation were weighed individually (designated as W1) and placed separately in petri dishes containing 2% agar gel. At regular intervals (1, 2, 3, 4, 5, 6, 7 and 8 hr), the tablets were removed from the petri dishes and excess water was removed carefully by using filter paper (Ramana et al., 2007) . The swollen tablets were reweighed (W2), the swelling index of each formulation was calculated using the formula Where, W2-weight of tablet after particular time interval W1-initial weight of tablet Evaluation of bio-adhesive strength of tablet Measurement of adhesion force was determined by using goat gastric mucus membrane. The tissues were washed thoroughly with phosphate buffer solution (pH 6.8) then the membrane was tied to the glass slide using rubber band. The glass slide was kept in a beaker which was filled with phosphate buffer solution at 37±1 C in such way that buffer just reaches the surface of mucosal membrane and kept it moist. The tablet to be tested was stuck on the mucus membrane and allow for 5min for swelling and then by using clip to attach the tablet. Then the weight on the left hand side was slowly added in an increment of 0.5g till the tablet separated from the membrane (Gupta et al., 1993) . From bio-adhesive strength, the force of adhesion was calculated using the formula.
( )
Ex-vivo mucoadhesion time
The ex-vivo mucoadhesion time was examined after application of tablet over excised goat mucosa for 30sec after previously being secured on glass slab and was immersed in a basket of the dissolution apparatus containing around 750ml of phosphate buffer, pH 6.8 at 37±1°C. The paddle of the dissolution apparatus was adjusted at a distance of 5cm from the tablet and rotated at 25rpm. The time for detachment from the mucosa was recorded (Chowdary, 2008) .
In-vitro drug release studies
The dissolution test apparatus (USP II) was used and the whole assembly was kept in a jacketed vessel of water maintained at 37±1 C. Bio adhesive tablet was stuck on to the bottom of the flask (so as to allow one sided release from the tablet). The beaker was filled with 900ml of phosphate buffer and was maintained at 50rpm under stirring conditions by means of a paddle fabricated for the purpose in a dissolution apparatus. At various time intervals samples of dissolution medium were withdrawn and filtered through Whatman filter paper no: 42. It was replaced immediately with an equal amount of fresh buffer. The samples were then analyzed UV spectrophotometrically at 238nm. Absorbance measured and % drug release was determined (Balamurugan et al., 2008) .
Stability studies
The selected F9 formulation was packed in PVC blister pack then they were stored at three different temperatures 4±2 C, 27±2 C and 45±2 C for 30days at RH 75±5%. At 15 days interval, the tablets were evaluated for their physical appearance, hardness, friability, in-vitro drug release (Matthews, 1999) .
Drug release kinetics
To study the release kinetics of in-vitro drug release, data was applied to kinetic models such as zero order, first order, Higuchi and Korsmeyer-Peppas.
Zero order
Drug dissolution from dosage forms that do not disaggregate and release the drug slowly can be represented by the equation: K0 -is the zero order release constant To study the release kinetics, data obtained from in vitro drug release studies were plotted as cumulative amount of drug released versus time.
First order
This model has also been used to describe absorption and/or elimination of some drugs, although it is difficult to conceptualize this mechanism on a theoretical basis. The release of the drug which followed first order kinetics can be expressed by the equation ⁄ where, C0 -is the initial concentration of drug K -is the first order constant t -is the time in hrs. The data obtained were plotted as log cumulative percentage of drug remaining vs. time which would yield a straight line with a slope of -K/2.303.
Higuchi
It describes the release of drugs from insoluble matrix as a square root of time dependent process based on Fickian diffusion.
Where, K is the constant reflecting the design variables of the system. Hence drug release rate is proportional to the reciprocal of the square rot time (Biswas et al., 2008) .
Korsmeyer Peppas
It derived a simple relationship which described drug release from a polymeric system equation. To find out the mechanism of drug release, first 60% drug release data were fitted in Korsmeyer-Peppas model.
Where, Mt / M∞ -is a fraction of drug released at time t, kis the release rate constant and n is the release exponent.
RESULTS AND DISCUSSION
All the formulations were evaluated for physical properties and hardness of the tablet in the range of 1-2kg/cm 2 .
Percentage weight loss in the friability test was less than 0.4% in all the formulation batches. Thicknesses of all the formulation was less than 3.5mm. Overall, the prepared tablet batches were of good quality with regard to hardness, friability, and thickness.
Bio-adhesive strength
All the formulation showed good mucoadhesion. The invitro bioadhesive strength study was performed on the modified physical balance to measure the force (N) required for detaching the tablet. The bioadhesion characteristics were affected by the type and concentration of the bioadhesive polymers. Viscosity of the polymer also affected the bioadhesive strength of the tablet. Chitosin batch (F4, F5, F6) showed very low bioadhesive strength, xanthan gum (F1, F2, F3) showed good mucoadhesion and guar gum (F7, F8, F9) showed highest adhesive strength.
Ex-vivo mucoadhesion time
Ex-Vivo Mucoadhesion time of all formulation (F1-F12) calculated by modified dissolution apparatus. In all the formulation Ex-vivo mucoadhesive time increased more than 6 hrs except formulations F4, F5, F6, F10, F11 it was decreased because of chitosin which displayed a much lower hydration capacity and a higher rate of erosion.
Swelling index
Batch F1-F3 showed 700% swelling in 8 hrs, batch F4-F6 
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showed good swelling (more than 800%); F7-F9 batch swelling index was 400% on 8 hr.
In-vitro drug release
From the overall dissolution profiles, it was concluded that the drug release rate decreased as the concentration of the polymer increased, in batch (F1-F6) which was also affected by the type of polymer used. And batch (F7-F9) guar gum with high concentration act as disintegrant and showed extended drug release which is the best in all the formulations.
Drug release kinetics
The straight line of linear regression analysis indicates zero order of the data yields the equation of best line with R 2 value 0.994 and the slope of line corresponds to the zero order rate constant was 8.33. The best linearity was found in zero order equation plot (R 2 = 0.994) indicating the release from system where release rate is concentration dependent. According to Korsmeyer, where n is the release exponent, indicative of mechanism of drug release. Fickian diffusional release and a case-II relaxation release are the limits of this phenomenon. Fickian diffusional release occurs by the usual molecular diffusion of the drug due to a chemical potential gradient. Case-II relaxation release is the drug transport mechanism associated with stresses and state transition in hydrophilic glassy polymers which swell in water or biological fluids. This term also includes polymer disentanglement and erosion. The value of the release exponent in Simvastatin extended release was obtained as 0.588 which follows Anomalous transport (0.45 < n < 0.89).
Stability study
According to ICH guidelines, 30 days stability study at 4±2°C, 27±2°C and 45±2°C for 30 days at RH 75±5% of optimized formulation (F9) was carried out. It showed negligible change over time for parameters like appearance, drug content, dissolution and assay etc., No significant difference in the drug content between initial and formulations stored at 4±2°C, 27±2°C and 45±2°C for 45 days at RH 75±5% for 30 days.
CONCLUSION
Literature review indicates that gastroretentive drug delivery systems can be used to increase the gastric residence time of dosage form, which led to an increased bioavailability of various drugs. Thus, in the present investigation, an attempt was made to deliver simvastatin via an oral bio-adhesive drug delivery system to the vicinity of the absorption site by prolonging the gastric residence time of the dosage form. For the formulation of the oral bioadhesive tablet, various hydrophilic polymers and their combinations were used in varying concentrations.
Tablets were subject to various evaluation parameters such as hardness, friability and drug content, bioadhesive strength study and in-vitro drug release study. It was revealed that tablets of all batches had acceptable physical parameters. Tablets of batch F9 have good mucoadhesion along with in-vitro drug release and thus were selected as an optimized batch. The present study shows that the hydrophilic gums obtained from natural sources can be used for designing a bio-adhesive controlled release drug delivery system. 
